Inventor · disambiguated record
Bohdan Waszkowycz
Also filed as: WASZKOWYCZ BOHDAN
25 granted patents·9 pending applications·136 citations·filing 1998–2024
95Inventor score
Files withCANCER RESEARCH TECH LTD15TULARIK LTD8CORCEPT THERAPEUTICS INC2BABU SRINIVASAN1BAESCHLIN DANIEL KASPAR1
Top patents by PatentIndex Score
34 records- 0192US11680068B2Compounds useful as RET inhibitorsCANCER RESEARCH TECH LTD·Filed 2022·Granted Jun 20, 2023·1 cites·14 claims
- 0290US11352361B2Compounds useful as RET inhibitorsCANCER RESEARCH TECH LTD·Filed 2018·Granted Jun 7, 2022·3 cites·22 claims
- 0390US7157585B2Serine protease inhibitorsTULARIK LTD·Filed 2005·Granted Jan 2, 2007·12 cites·27 claims
- 0489US10954241B2Heterocyclic compounds as ret kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2017·Granted Mar 23, 2021·3 cites·29 claims
- 0589US8461328B2Tricyclic heterocyclic compounds, compositions and methods of use thereofBABU SRINIVASAN·Filed 2011·Granted Jun 11, 2013·36 cites·18 claims
- 0688US10844067B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2017·Granted Nov 24, 2020·4 cites·27 claims
- 0787US11548896B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2021·Granted Jan 10, 2023·1 cites·30 claims
- 0885US11661423B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2020·Granted May 30, 2023·1 cites·24 claims
- 0985US2025236624A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 1084US12129236B2PARG inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2021·Granted Oct 29, 2024·1 cites·14 claims
- 1183US10508086B2PARG inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2015·Granted Dec 17, 2019·3 cites·12 claims
- 1282US2025223266A1Parg inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 1382US2025243202A1Compounds Useful as RET InhibitorsCANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 1481US8557797B2Triazolopyridine derivatives and their therapeutic useFINCH HARRY·Filed 2010·Granted Oct 15, 2013·7 cites·20 claims
- 1581US2024132504A1Compounds Useful as RET InhibitorsCANCER RESEARCH TECH LTD·Filed 2023·Application pending·0 cites
- 1680US6262069B11-amino-7-isoquinoline derivatives as serine protease inhibitorsPROTHERICS MOLECULAR DESIGN LT·Filed 1998·Granted Jul 17, 2001·33 cites·28 claims
- 1779US6420438B11-amino-7-isoquinoline derivatives as serine protease inhibitorsTULARIK LTD·Filed 2001·Granted Jul 16, 2002·6 cites·16 claims
- 1878US8653089B2Heterocyclic compounds and methods of useHEALD ROBERT·Filed 2012·Granted Feb 18, 2014·5 cites·3 claims
- 1978US2023339954A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2022·Application pending·0 cites
- 2076US2024116938A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2023·Application pending·0 cites
- 2171US7074934B2Serine protease inhibitorsTULARIK LTD·Filed 2001·Granted Jul 11, 2006·5 cites·35 claims
- 2270US2025092023A1Piperazine indazole glucocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2369US8450314B2Pyrimidopyridazine derivatives useful as P38 MAPK inhibitorsBESWICK AMANDA·Filed 2010·Granted May 28, 2013·6 cites·20 claims
- 2468US10975056B2Substituted pyridines as inhibitors of DNMT1GLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Apr 13, 2021·1 cites·21 claims
- 2568US6916957B2Serine protease inhibitorsTULARIK LTD·Filed 2000·Granted Jul 12, 2005·4 cites·24 claims
- 2667US12098144B2Piperazine indazole glucocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2022·Granted Sep 24, 2024·0 cites·28 claims
- 2763US10239843B22,4-dioxo-quinazoline-6-sulfonamide derivatives as inhibitors of PARGCANCER RESEARCH TECH LTD·Filed 2015·Granted Mar 26, 2019·1 cites·18 claims
- 2862US7928137B2Meta-benzamidine derivatives as serine protease inhibitorsTULARIK LTD·Filed 2007·Granted Apr 19, 2011·0 cites·16 claims
- 2960US9090628B2Benzoxazepin compounds selective for PI3K P110 delta and methods of useHEFFRON TIMOTHY·Filed 2012·Granted Jul 28, 2015·1 cites·6 claims
- 3059US7067516B2Serine protease inhibitorsTULARIK LTD·Filed 2001·Granted Jun 27, 2006·2 cites·41 claims
- 3154US7381734B2Serine protease inhibitorsTULARIK LTD·Filed 2005·Granted Jun 3, 2008·0 cites·20 claims
- 3252US7220781B2Meta-benzamidine derivatives as serine protease inhibitorsTULARIK LTD·Filed 2004·Granted May 22, 2007·0 cites·23 claims
- 3352US2023227427A1Il-17a modulatorsSANOFI SA·Filed 2021·Application pending·0 cites
- 3441US2013012485A1Organic compoundsBAESCHLIN DANIEL KASPAR·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →